New report finds that Trikafta patients’ admissions to hospital fell by an average of 65 per cent over one year – but at a ...
Rena Barrow has two sons with cystic fibrosis, born 20 years apart — but they faced the same terrible delay in diagnosis.
Leader Post on MSN7d
Cystic fibrosis drug now available to more people in SaskatchewanThe change comes in light of a recommendation made earlier this month by the Canadian Agency for Drugs and Technologies in ...
Arcturus Therapeutics expects interim results for LUNAR-CF and LUNAR-OTC in 2025. Learn why ARCT stock presents an ...
News Medical on MSN2d
Enterprise Therapeutics publishes on medicinal chemistry of ETD001, a novel inhaled ENaC blocker for treatment of cystic fibrosisEnterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of people with respiratory diseases, today ...
The firm's chief scientific officer called the achievement "a major milestone for Spirovant and for the cystic fibrosis ...
The Saskatchewan government has announced it is increasing coverage for a drug used to treat cystic fibrosis. Patients and ...
More cystic fibrosis (CF) patients in Saskatchewan now have access to Trikafta, a groundbreaking medication that improves ...
The provincial government announced Monday that more cystic fibrosis (CF) patients in Saskatchewan are now eligible for ...
"We envisage that this method of drug delivery can also be used to treat other lung conditions such as cystic fibrosis, infections and pulmonary emphysema. In other words, methods other than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback